Osuch, E. | Search bioRxiv

bioRxiv2024

Template-driven dynamic functional network connectivity predicts medication response for major depression and bipolar disorders

The process of finding reliable treatment for major depression and bipolar disorder can be arduous. The myriad behavioral symptoms presented by patients and resistance to treatment from particular medication classes complicate standard diagnostic and prescription methodologies, often requiring multiple attempted treatments during which symptoms may still be present. Physiological information such as neuroimaging scans may help to alleviate some of the uncertainty surrounding diagnosis and treatment when incorporated into a clinical setting. Changes in functional magnetic resonance imaging show particular promise, as the incorporation of dynamical information may provide insights into physiological changes prior to static, structural changes. In this work, we present a novel method for generating robust and replicable dynamic functional network connectivity (dFNC) features from neuroimaging data using a template of dynamic states derived from a large, non-affected data set. We demonstrate that this template-driven dFNC approach expands on standard dFNC approaches by allowing for the derivation of a continuous state-contribution time series. We demonstrate that the derived biomarkers can support high predictive performance for the identification of medication class and non-responders while also expanding the set of biomarkers available for studying differences in mood disorder medication response.

neuroscience↗

bioRxiv2022

Machine Learning Predicts Treatment Response in Bipolar & Major Depressive Disorders

Diagnosis of bipolar disorder (BD) patients with complex symptoms presents a challenge to clinicians. Patients tend to spend more time in a depressive state than a manic state. In such complex cases, the current Diagnostic and Statistical Manual (DSM), which is not based on pathophysiology, can lead to misdiagnosis as major depressive disorder (MDD) and an imperfect or even harmful medication response. A biologically-based classification algorithm is needed to improve the accuracy of diagnosis. Osuch et al. (2018) presented a kernel support vector machine (SVM) algorithm to predict the medication-class of response from new patient samples whose diagnoses were unclear. Here we also utilize the kernel support vector machine (SVM) algorithm but with a few novel contributions. We applied the robust, fully automated neuromark independent component analysis (ICA) framework to extract comparable features in a multi-dataset setting and learn a kernel function for support vector machine (SVM) on multiple feature subspaces. The neuromark framework successfully replicates the prior result with 95.45% accuracy (sensitivity 90.24%, specificity 92.3%). To further evaluate the generalizability of our approach, we incorporated two additional datasets comprising bipolar disorder (BD) and major depressive disorder (MDD) patients. We validated the trained algorithm on these datasets, resulting in a testing accuracy of up to 89% (sensitivity 0.88, specificity 0.89) without using site or scanner harmonization techniques. We also translated the model to predict improvement scores of major depressive disorder (MDD) with up to 70% accuracy. This approach reveals some salient biological markers of medication-class of response within mood disorders. HighlightsO_LIWe demonstrate a DSM-free approach for predicting treatment response from resting-state functional magnetic resonance imaging (fMRI) data. C_LIO_LIWe identify several replicable biomarkers using the approach. C_LIO_LIOur work has potential for clinical application by replacing trial-and-error in treating complex psychiatric disorders. C_LI

neuroscience↗